In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this fifth episode, Joel sits down with Brian Leyland-Jones, MB BS, PhD, CMO, National Foundation for Cancer Research and Peter Kuhn, PhD, Dean's Professor of Biological Sciences, Professor of Biological Sciences, Medicine, Biomedical Engineering, Aerospace and Mechanical Engineering and Urology, to explore:

• Historical perspective on personalized approaches to cancer treatment
• Liquid biopsy as a means to facilitate adaptive treatment regimens tailored to individual cancers
• Vision of where the field is going and future management paradigms

©2023 Lumanity Inc.